Met Life Investment Management, LLC Natera, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 7,057 shares of NTRA stock, worth $935,969. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,057
Previous 7,134
1.08%
Holding current value
$935,969
Previous $906,000
23.29%
% of portfolio
0.01%
Previous 0.01%
Shares
61 transactions
Others Institutions Holding NTRA
# of Institutions
635Shares Held
123MCall Options Held
821KPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA12.3MShares$1.63 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$898 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.74MShares$894 Million0.12% of portfolio
-
Jpmorgan Chase & CO New York, NY6.7MShares$889 Million0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.43MShares$588 Million3.74% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $12.9B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...